Cost Analysis of the Treatment of Schizophrenia in the UK
- 1 January 1998
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics
- Vol. 13 (5) , 575-588
- https://doi.org/10.2165/00019053-199813050-00010
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Efficacy and safety of risperidone in the long-term treatment of patients with schizophreniaClinical Therapeutics, 1995
- Considering Neuroleptic Maintenance and Taper on a ContinuumArchives of General Psychiatry, 1995
- Cost effectiveness of clozapine in neuroleptic-resistant schizophreniaAmerican Journal of Psychiatry, 1993
- A Controlled Trial of Home-Based Acute Psychiatric ServicesThe British Journal of Psychiatry, 1993
- Assessment of Costs and Benefits of Drug Therapy for Treatment-Resistant Schizophrenia in the United KingdomThe British Journal of Psychiatry, 1993
- The Positive-Negative Distinction in SchizophreniaArchives of General Psychiatry, 1992
- The TAPS Project. 3: Predicting the Community Costs of Closing Psychiatric HospitalsThe British Journal of Psychiatry, 1990
- Suicide and schizophrenia: data from a prospective community treatment study [published erratum appears in Am J Psychiatry 1990 Aug;147(8):1110]American Journal of Psychiatry, 1990
- The natural history of schizophrenia: a five-year follow-up study of outcome and prediction in a representative sample of schizophrenicsPsychological Medicine. Monograph Supplement, 1989
- Negative and Positive Symptoms in Schizophrenia and Depression: A FollowupSchizophrenia Bulletin, 1984